ENCell Co., Ltd. (KOSDAQ:456070)

Market Cap	148.71B
Revenue	n/a
Net Income	n/a
Shares Out	10.89M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,948
Average Volume	52,250
Open	13,700
Previous Close	13,570
Day's Range	13,600 - 14,000
52-Week Range	12,100 - 45,800
Beta	n/a
RSI	37.92
Earnings Date	n/a

About ENCell

ENCell Co., Ltd. develops cell/gene-based biopharmaceutical products in South Korea. The company develops EN00, an allogeneic umbilical cord-derived mesenchymal stem cell treatment for Charcot-Marie-Tooth disease It also provides contracting development and manufacturing services for biopharmaceutical products. The company was founded in 2018 and is based in Seoul, South Korea.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 456070